MARKET

HMTXF

HMTXF

Hemostemix
OTCMQB
0.061
NaN%
Closed 09:30 05/12 EDT
OPEN
--
PREV CLOSE
0.061
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.281
52 WEEK LOW
0.024
MARKET CAP
9.06M
P/E (TTM)
-3.1771
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HMTXF last week (0505-0509)?
Weekly Report · 21h ago
Hemostemix at Invest Stuttgart
Newsfile · 4d ago
Weekly Report: what happened at HMTXF last week (0428-0502)?
Weekly Report · 05/05 12:17
Weekly Report: what happened at HMTXF last week (0421-0425)?
Weekly Report · 04/28 12:31
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
Newsfile · 04/23 15:53
Weekly Report: what happened at HMTXF last week (0414-0418)?
Weekly Report · 04/21 12:30
Weekly Report: what happened at HMTXF last week (0407-0411)?
Weekly Report · 04/14 12:14
Weekly Report: what happened at HMTXF last week (0331-0404)?
Weekly Report · 04/07 12:14
More
About HMTXF
Hemostemix Inc. is an autologous stem cell therapy platform company. The Company has developed, patented, and is scaling and selling autologous (patient’s own) blood-based stem cell therapies that include angiogenic cell precursors (ACP-01), later neural cell precursors (NCP-01), and cardiomyocyte cell precursors (CCP-01). It holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including ACP-01, CCP-01 and NCP-01. ACP-01 is a clinically relevant and statistically significant treatment for peripheral arterial disease, chronic limb-threatening ischemia, non-ischemic dilated cardiomyopathy, ischemic cardiomyopathy, congestive heart failure, and angina. It has completed a Phase II clinical trial for chronic limb-threatening ischemia. It has two wholly owned subsidiaries, Kwalata Trading Limited and PreCerv Inc. PreCerv Inc. holds a global field of use license to ACP-01 & NCP-01 for the treatment of conditions of the central and peripheral nervous system.

Webull offers Hemostemix Inc stock information, including OTCMQB: HMTXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HMTXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HMTXF stock methods without spending real money on the virtual paper trading platform.